Atlas Trials

Xianglin Yuan

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xianglin Yuan

RecordFirmDate
A Single-arm, Multicenter Clinical Study of Iparomlimab and Toripalimab in Combination With Bevacizumab and Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (NCT07619235)Xianglin Yuan2026-07-01
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer (NCT06592287)Xianglin Yuan2024-09-30

Track Xianglin Yuan automatically

Every clearance here is in the API, with alerts when new ones post.